EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Nuclear factor erythroid 2 related Factor-1 is stimulated by the nutraceutical celastrol at proteasome inhibiting doses

Alireza Ahadiabhari, Lei Li, Shennan Su, Sherin McDonald, Scott B Widenmaier

Biochemical and Biophysical Research Communications · 2025

DOI: 10.1016/j.bbrc.2025.152193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2025. Verfasst von Alireza Ahadiabhari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Physiology, and Pharmacology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. Hauptthemen laut MEDLINE: Triterpenes, Proteasome Inhibitors, NF-E2-Related Factor 1, Dietary Supplements. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canadian Institutes of Health Research, Institute of Nutrition Metabolism and Diabetes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mechanism by which many nutraceuticals promote health is incompletely understood. Some act by inhibiting the proteasome. Nuclear Factor Erythroid 2 Related Factor 1 (NRF1) is a stress-protective transcription factor that is stimulated by suppressed proteasome activity, such as upon exposure to proteasome inhibitor. Here, we investigated whether nutraceutical compounds with proteasome inhibitory properties stimulate NRF1 to regulate stress-protective genes. Using a luciferase-based promoter reporting the activity of NRF1 and its homolog NRF2 in Hepa 1-6 cells, we performed a small nutraceutical screen and identified that 2 and 4 μM treatment with celastrol exhibited robust stimulatory effect. Using the same reporter in wild type and gene deleted murine embryonic fibroblasts, we found that Nrf1 deficiency reduced celastrol-stimulated luciferase activity. In Hep3B cells, we found that 2 μM celastrol, but not lower concentrations, increased NRF1 processing and nuclear accumulation while also suppressing trypsin-like, chymotrypsin-like, and caspase-like activities of the proteasome, similar to proteasome inhibiting drugs. However, using control and NRF1 deficient Hep3B cells treated with 2 μM celastrol, MG132, bortezomib, or vehicle, we found distinct effects by celastrol versus MG132 and bortezomib on NRF1-dependent regulation of stress-protective genes. Our results show that celastrol can stimulate NRF1 at concentrations that suppress proteasome activity, but its effect on gene regulation is distinct compared to proteasome inhibitor. Overall, our findings reveal that NRF1 may play a role in the health promoting effects of celastrol and possibly other nutraceuticals with proteasome inhibitory properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriterpenesProteasome InhibitorsNF-E2-Related Factor 1Dietary SupplementsPentacyclic TriterpenesAnimalsMiceHumansProteasome Endopeptidase ComplexNF-E2-Related Factor 2Cell LineDose-Response Relationship, DrugCell Line, Tumor

Substanzen

celastrolPentacyclic TriterpenesTriterpenesProteasome InhibitorsNF-E2-Related Factor 1Proteasome Endopeptidase ComplexNF-E2-Related Factor 2

Autor:innen und Institutionen

  • Department of Anatomy, Physiology, and Pharmacology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Department of Anatomy, Physiology, and Pharmacology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. Electronic address: scott.widenmaier@usask.ca.

Förderung

  • Canadian Institutes of Health Research
  • Institute of Nutrition Metabolism and Diabetes

Zitieren

APA

Ahadiabhari, A., Li, L., Su, S., McDonald, S., & Widenmaier, S. B. (2025). Nuclear factor erythroid 2 related Factor-1 is stimulated by the nutraceutical celastrol at proteasome inhibiting doses. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2025.152193

Vancouver

Ahadiabhari A, Li L, Su S, McDonald S, Widenmaier SB. Nuclear factor erythroid 2 related Factor-1 is stimulated by the nutraceutical celastrol at proteasome inhibiting doses. Biochemical and Biophysical Research Communications. 2025. doi:10.1016/j.bbrc.2025.152193

BibTeX
@article{Ahadiabhari2025,
  author = {Ahadiabhari, Alireza and Li, Lei and Su, Shennan and McDonald, Sherin and Widenmaier, Scott B},
  title = {Nuclear factor erythroid 2 related Factor-1 is stimulated by the nutraceutical celastrol at proteasome inhibiting doses},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2025},
  doi = {10.1016/j.bbrc.2025.152193}
}
Kostenlos starten →